| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 6.834 | 16.863 | 20.291 | 19.990 | 29.252 | 30.773 | 10.867 | 6.737 |
| Total Income - EUR | - | - | 6.834 | 16.947 | 20.291 | 19.990 | 29.252 | 30.773 | 11.058 | 6.737 |
| Total Expenses - EUR | - | - | 1.956 | 11.393 | 11.924 | 12.289 | 1.500 | 1.241 | 2.887 | 5.582 |
| Gross Profit/Loss - EUR | - | - | 4.878 | 5.554 | 8.367 | 7.701 | 27.752 | 29.532 | 8.171 | 1.155 |
| Net Profit/Loss - EUR | - | - | 4.673 | 5.045 | 7.758 | 7.102 | 26.892 | 28.628 | 6.889 | 993 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Tara Sox Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 4.967 | 5.797 | 9.369 | 7.897 | 27.187 | 28.885 | 23.974 | 8.013 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 641 | 959 | 578 | 1.585 | 6.488 | 9.470 | 36 | 0 |
| Cash | - | - | 4.326 | 4.838 | 8.791 | 6.312 | 20.699 | 19.415 | 23.938 | 8.013 |
| Shareholders Funds | - | - | 4.782 | 5.161 | 7.885 | 7.226 | 27.013 | 28.749 | 7.011 | 7.964 |
| Social Capital | - | - | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | - | - | 185 | 636 | 1.484 | 671 | 174 | 136 | 16.964 | 49 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Tara Sox Med Srl